Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized study.
about
Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects.Low-dose interleukin-2 as a modulator of Treg homeostasis after HSCT: current understanding and future perspectives.T-Cell Manipulation Strategies to Prevent Graft-Versus-Host Disease in Haploidentical Stem Cell Transplantation.Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
P2860
Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Prophylactic use of low-dose i ...... lantation: A randomized study.
@en
Prophylactic use of low-dose i ...... lantation: A randomized study.
@nl
type
label
Prophylactic use of low-dose i ...... lantation: A randomized study.
@en
Prophylactic use of low-dose i ...... lantation: A randomized study.
@nl
prefLabel
Prophylactic use of low-dose i ...... lantation: A randomized study.
@en
Prophylactic use of low-dose i ...... lantation: A randomized study.
@nl
P2093
P2860
P1433
P1476
Prophylactic use of low-dose i ...... lantation: A randomized study.
@en
P2093
Chen-Hua Yan
Feng-Rong Wang
Jing-Zhi Wang
Kai-Yan Liu
Lan-Ping Xu
Xiang-Yu Zhao
Xiao-Hui Zhang
Xiao-Su Zhao
P2860
P304
P356
10.1080/2162402X.2016.1250992
P577
2016-10-28T00:00:00Z